Comparing routine and symptom-based PPI therapy after a procedure for esophageal achalasia
Official title: Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia. Randomized Open-label Clinical Trial
Run by Centre Hospitalier Universitaire de Nīmes · NCT05899842 · Data updated 2026-11-12
This study is testing whether giving patients with esophageal achalasia a routine 12-month prescription for heartburn medication after a specific procedure can help prevent throat inflammation better than only giving the medication when they have symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 132 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 4 sites (Marseille and 3 other locations) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT05899842 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with esophageal achalasia who are scheduled for POEM and have an Eckardt score greater than 3.
✕Probably not a fit
Patients with contraindications to PPIs or those who have undergone previous anti-reflux surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of routine prescription of protein pump inhibitors (PPIs) for 12 months following Per Oral Endoscopic Myotomy (POEM) in patients with esophageal achalasia. The researchers aim to determine if this approach can reduce the incidence of esophagitis related to gastroesophageal reflux compared to a strategy that prescribes PPIs only when symptoms arise. Patients eligible for the study must have a high Eckardt score indicating significant achalasia symptoms and must provide informed consent. The study is conducted at multiple locations in France, including Nīmes, Marseille, and Montpellier.
Why it matters
Potential benefit: If successful, this study could lead to improved management of gastroesophageal reflux in patients undergoing POEM for achalasia.
How similar studies have gone: While there is limited research on systematic PPI use post-POEM, the approach is novel and has not been extensively tested in this specific context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with an indication for esophageal POEM for achalasia * Patient with all types of achalasia with Eckardt score \> 3 * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan Exclusion Criteria: * Patient with contraindications to PPIs * Patient with mediastinal and esophageal neoplasia * Patient with a history of Heller myotomy surgery * Patients requiring any type of anti-reflux valve surgery * The subject is in a period of exclusion determined by a previous study * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * Patient is pregnant, parturient or breastfeeding
Where it's running
-
Ap-Hm
Marseille, France Recruiting -
CHU de Montpellier
Montpellier, France Recruiting -
Clinique mutualiste Beausoleil
Montpellier, France Recruiting -
CHU de Nîmes
Nîmes, France Recruiting
Study contacts
- Principal investigator: Antoine Debourdeau — CHU de Nimes
- Study coordinator: Antoine Debourdeau
- Email: a-debourdeau@chu-montpellier.fr
- Phone: 06.68.31.94.89
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
POEM vs Heller myotomy with Dor fundoplication for achalasia
This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.
-
Comparing Botox and surgery for stomach drainage during esophagectomy
This study is testing whether Botox injections can help people who have had esophagus surgery manage delayed stomach emptying just as well as surgery can.
-
Investigating the impact of malnutrition on breathing and kidney function in achalasia patients undergoing POEM surgery
This study is testing how malnutrition affects breathing and kidney health in patients with achalasia who are having a specific surgery called POEM.
-
Evaluating esophageal clearance in achalasia using advanced imaging techniques
This study is testing if a new way to measure how well the esophagus clears food can replace an older method that uses radiation for patients with achalasia who have had a specific surgery.
-
New treatments for esophageal achalasia
This study is testing four different treatment options for esophageal achalasia to see which one helps patients feel better, especially those who haven't had success with other treatments.
-
Registry for identifying risk factors of esophageal cancer
This study is trying to find out if certain blood and tissue markers can help identify people at risk for esophageal cancer by looking at their medical history and samples.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.